Recent reports from the United States indicate serious concerns regarding flunitrazepam, more commonly known by its trade name, Rohypnol. While significant problems with this drug have not yet been noted in Canada, the apparent escalation of its popularity elsewhere in North America, as well as in Europe and Asia, serves as a warning of potential problems in this country. The manufacturer's marking are similar to those found on other pills, including Rivotril and Valium. Rohypnol cannot be prescribed or sold legally in Canada, however, it can be brought into the country in limited amounts if prescribed by a foreign physician. In March 1995, this drug became the first benzodiazepine to be moved to Schedule III by the World Health Organization, requiring more thorough record keeping on its distribution.
Continued use can result in addiction.
Adverse effects can include loss of memory, impaired judgement, dizziness, and prolonged periods of blackout. Although a sedative, Rohypnol can induce aggressive behaviour. This drug has been associated with date rape. Several arrests have been made in cases where it has allegedly been added to a woman's drink without here knowledge, for the purpose of reducing resistance. It is odourless, colourless and tasteless when added to either alcoholic or non-alcoholic beverages.